Did the FDA approve Vitestro’s Aletta robotic blood-draw device in the U.S.?

Yes. The FDA cleared Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without hands-on human help. The article frames it as a category-defining milestone for robotic phlebotomy, with attention now shifting to deployment economics, workflow fit, and adoption pace.